Neuro-psychiatric effects of adrenergic beta-receptor blocking agents: proceedings of a symposium held in Copenhagen, Denmark, October 20 - 21, 1975 ; 30 tables
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
München [u.a.]
Urban & Schwarzenberg
1976
|
| Ausgabe: | 1. Aufl. |
| Schriftenreihe: | Advances in clinical pharmacology
12 |
| Schlagworte: | |
| Beschreibung: | X, 120 S. Ill., graph. Darst. |
| ISBN: | 354107891X |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV000950105 | ||
| 003 | DE-604 | ||
| 005 | 20130708 | ||
| 007 | t | ||
| 008 | 890315s1976 ad|| |||| 10||| eng d | ||
| 020 | |a 354107891X |9 3-541-07891-X | ||
| 035 | |a (OCoLC)4438737 | ||
| 035 | |a (DE-599)BVBBV000950105 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-355 |a DE-20 |a DE-29 |a DE-188 |a DE-578 | ||
| 050 | 0 | |a RM666.P85 | |
| 082 | 0 | |a 615/.78 | |
| 084 | |a VS 7108 |0 (DE-625)147698:261 |2 rvk | ||
| 084 | |a XI 5793 |0 (DE-625)153017:13002 |2 rvk | ||
| 084 | |a YH 2100 |0 (DE-625)153525:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Neuro-psychiatric effects of adrenergic beta-receptor blocking agents |b proceedings of a symposium held in Copenhagen, Denmark, October 20 - 21, 1975 ; 30 tables |c arranged by ICI Pharmaceuticals Division. Vol. ed. Carl Carlsson ... |
| 250 | |a 1. Aufl. | ||
| 264 | 1 | |a München [u.a.] |b Urban & Schwarzenberg |c 1976 | |
| 300 | |a X, 120 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Advances in clinical pharmacology |v 12 | |
| 650 | 4 | |a Bêtabloquants - Congrès | |
| 650 | 4 | |a Propranolol - Congrès | |
| 650 | 4 | |a Adrenergic beta blockers |v Congresses | |
| 650 | 4 | |a Adrenergic beta-Antagonists |x pharmacology |v Congresses | |
| 650 | 4 | |a Adrenergic beta-Antagonists |x therapeutic use |v Congresses | |
| 650 | 4 | |a Mental Disorders |x drug therapy |v Congresses | |
| 650 | 4 | |a Nervous System Diseases |x drug therapy |v Congresses | |
| 650 | 4 | |a Neuropsychopharmacology |v Congresses | |
| 650 | 4 | |a Propranolol |v Congresses | |
| 650 | 4 | |a Propranolol |x pharmacology |v Congresses | |
| 650 | 4 | |a Propranolol |x therapeutic use |v Congresses | |
| 650 | 0 | 7 | |a Beta-Blocker |0 (DE-588)4006088-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Neuropsychiatrie |0 (DE-588)4171595-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Beta-Blocker |0 (DE-588)4006088-3 |D s |
| 689 | 0 | 1 | |a Neuropsychiatrie |0 (DE-588)4171595-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Carlsson, Carl |e Sonstige |4 oth | |
| 710 | 2 | |a Imperial Chemical Industries Limited |b Pharmaceuticals Division |e Sonstige |0 (DE-588)2043054-1 |4 oth | |
| 830 | 0 | |a Advances in clinical pharmacology |v 12 |w (DE-604)BV000894821 |9 12 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000579719 | ||
Datensatz im Suchindex
| _version_ | 1804115380227014656 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV000950105 |
| callnumber-first | R - Medicine |
| callnumber-label | RM666 |
| callnumber-raw | RM666.P85 |
| callnumber-search | RM666.P85 |
| callnumber-sort | RM 3666 P85 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | VS 7108 XI 5793 YH 2100 |
| ctrlnum | (OCoLC)4438737 (DE-599)BVBBV000950105 |
| dewey-full | 615/.78 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.78 |
| dewey-search | 615/.78 |
| dewey-sort | 3615 278 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| edition | 1. Aufl. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02339nam a2200565 cb4500</leader><controlfield tag="001">BV000950105</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130708 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">890315s1976 ad|| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">354107891X</subfield><subfield code="9">3-541-07891-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)4438737</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000950105</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM666.P85</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.78</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 7108</subfield><subfield code="0">(DE-625)147698:261</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5793</subfield><subfield code="0">(DE-625)153017:13002</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YH 2100</subfield><subfield code="0">(DE-625)153525:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Neuro-psychiatric effects of adrenergic beta-receptor blocking agents</subfield><subfield code="b">proceedings of a symposium held in Copenhagen, Denmark, October 20 - 21, 1975 ; 30 tables</subfield><subfield code="c">arranged by ICI Pharmaceuticals Division. Vol. ed. Carl Carlsson ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. Aufl.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">München [u.a.]</subfield><subfield code="b">Urban & Schwarzenberg</subfield><subfield code="c">1976</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X, 120 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Advances in clinical pharmacology</subfield><subfield code="v">12</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bêtabloquants - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Propranolol - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adrenergic beta blockers</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adrenergic beta-Antagonists</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adrenergic beta-Antagonists</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental Disorders</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nervous System Diseases</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neuropsychopharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Propranolol</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Propranolol</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Propranolol</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Beta-Blocker</subfield><subfield code="0">(DE-588)4006088-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Neuropsychiatrie</subfield><subfield code="0">(DE-588)4171595-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Beta-Blocker</subfield><subfield code="0">(DE-588)4006088-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Neuropsychiatrie</subfield><subfield code="0">(DE-588)4171595-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carlsson, Carl</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Imperial Chemical Industries Limited</subfield><subfield code="b">Pharmaceuticals Division</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)2043054-1</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Advances in clinical pharmacology</subfield><subfield code="v">12</subfield><subfield code="w">(DE-604)BV000894821</subfield><subfield code="9">12</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000579719</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV000950105 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:21:41Z |
| institution | BVB |
| institution_GND | (DE-588)2043054-1 |
| isbn | 354107891X |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000579719 |
| oclc_num | 4438737 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-20 DE-29 DE-188 DE-578 |
| owner_facet | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-20 DE-29 DE-188 DE-578 |
| physical | X, 120 S. Ill., graph. Darst. |
| publishDate | 1976 |
| publishDateSearch | 1976 |
| publishDateSort | 1976 |
| publisher | Urban & Schwarzenberg |
| record_format | marc |
| series | Advances in clinical pharmacology |
| series2 | Advances in clinical pharmacology |
| spelling | Neuro-psychiatric effects of adrenergic beta-receptor blocking agents proceedings of a symposium held in Copenhagen, Denmark, October 20 - 21, 1975 ; 30 tables arranged by ICI Pharmaceuticals Division. Vol. ed. Carl Carlsson ... 1. Aufl. München [u.a.] Urban & Schwarzenberg 1976 X, 120 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Advances in clinical pharmacology 12 Bêtabloquants - Congrès Propranolol - Congrès Adrenergic beta blockers Congresses Adrenergic beta-Antagonists pharmacology Congresses Adrenergic beta-Antagonists therapeutic use Congresses Mental Disorders drug therapy Congresses Nervous System Diseases drug therapy Congresses Neuropsychopharmacology Congresses Propranolol Congresses Propranolol pharmacology Congresses Propranolol therapeutic use Congresses Beta-Blocker (DE-588)4006088-3 gnd rswk-swf Neuropsychiatrie (DE-588)4171595-0 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Beta-Blocker (DE-588)4006088-3 s Neuropsychiatrie (DE-588)4171595-0 s DE-604 Carlsson, Carl Sonstige oth Imperial Chemical Industries Limited Pharmaceuticals Division Sonstige (DE-588)2043054-1 oth Advances in clinical pharmacology 12 (DE-604)BV000894821 12 |
| spellingShingle | Neuro-psychiatric effects of adrenergic beta-receptor blocking agents proceedings of a symposium held in Copenhagen, Denmark, October 20 - 21, 1975 ; 30 tables Advances in clinical pharmacology Bêtabloquants - Congrès Propranolol - Congrès Adrenergic beta blockers Congresses Adrenergic beta-Antagonists pharmacology Congresses Adrenergic beta-Antagonists therapeutic use Congresses Mental Disorders drug therapy Congresses Nervous System Diseases drug therapy Congresses Neuropsychopharmacology Congresses Propranolol Congresses Propranolol pharmacology Congresses Propranolol therapeutic use Congresses Beta-Blocker (DE-588)4006088-3 gnd Neuropsychiatrie (DE-588)4171595-0 gnd |
| subject_GND | (DE-588)4006088-3 (DE-588)4171595-0 (DE-588)1071861417 |
| title | Neuro-psychiatric effects of adrenergic beta-receptor blocking agents proceedings of a symposium held in Copenhagen, Denmark, October 20 - 21, 1975 ; 30 tables |
| title_auth | Neuro-psychiatric effects of adrenergic beta-receptor blocking agents proceedings of a symposium held in Copenhagen, Denmark, October 20 - 21, 1975 ; 30 tables |
| title_exact_search | Neuro-psychiatric effects of adrenergic beta-receptor blocking agents proceedings of a symposium held in Copenhagen, Denmark, October 20 - 21, 1975 ; 30 tables |
| title_full | Neuro-psychiatric effects of adrenergic beta-receptor blocking agents proceedings of a symposium held in Copenhagen, Denmark, October 20 - 21, 1975 ; 30 tables arranged by ICI Pharmaceuticals Division. Vol. ed. Carl Carlsson ... |
| title_fullStr | Neuro-psychiatric effects of adrenergic beta-receptor blocking agents proceedings of a symposium held in Copenhagen, Denmark, October 20 - 21, 1975 ; 30 tables arranged by ICI Pharmaceuticals Division. Vol. ed. Carl Carlsson ... |
| title_full_unstemmed | Neuro-psychiatric effects of adrenergic beta-receptor blocking agents proceedings of a symposium held in Copenhagen, Denmark, October 20 - 21, 1975 ; 30 tables arranged by ICI Pharmaceuticals Division. Vol. ed. Carl Carlsson ... |
| title_short | Neuro-psychiatric effects of adrenergic beta-receptor blocking agents |
| title_sort | neuro psychiatric effects of adrenergic beta receptor blocking agents proceedings of a symposium held in copenhagen denmark october 20 21 1975 30 tables |
| title_sub | proceedings of a symposium held in Copenhagen, Denmark, October 20 - 21, 1975 ; 30 tables |
| topic | Bêtabloquants - Congrès Propranolol - Congrès Adrenergic beta blockers Congresses Adrenergic beta-Antagonists pharmacology Congresses Adrenergic beta-Antagonists therapeutic use Congresses Mental Disorders drug therapy Congresses Nervous System Diseases drug therapy Congresses Neuropsychopharmacology Congresses Propranolol Congresses Propranolol pharmacology Congresses Propranolol therapeutic use Congresses Beta-Blocker (DE-588)4006088-3 gnd Neuropsychiatrie (DE-588)4171595-0 gnd |
| topic_facet | Bêtabloquants - Congrès Propranolol - Congrès Adrenergic beta blockers Congresses Adrenergic beta-Antagonists pharmacology Congresses Adrenergic beta-Antagonists therapeutic use Congresses Mental Disorders drug therapy Congresses Nervous System Diseases drug therapy Congresses Neuropsychopharmacology Congresses Propranolol Congresses Propranolol pharmacology Congresses Propranolol therapeutic use Congresses Beta-Blocker Neuropsychiatrie Konferenzschrift |
| volume_link | (DE-604)BV000894821 |
| work_keys_str_mv | AT carlssoncarl neuropsychiatriceffectsofadrenergicbetareceptorblockingagentsproceedingsofasymposiumheldincopenhagendenmarkoctober2021197530tables AT imperialchemicalindustrieslimitedpharmaceuticalsdivision neuropsychiatriceffectsofadrenergicbetareceptorblockingagentsproceedingsofasymposiumheldincopenhagendenmarkoctober2021197530tables |